Manual Cardiopulmonary Resuscitation Machine Market Comprehensive Report: 200+ Pages | 2026–2034

Manual Cardiopulmonary Resuscitation Machine by Application (Medical Institutions, First Aid Training, Others), by Types (For Medical Use, Household Use), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 165

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 165

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Manual Cardiopulmonary Resuscitation Machine Market Size | CAGR 2019 Forecast 2033

Manual Cardiopulmonary Resuscitation Machine Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 165

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 165

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Manual Cardiopulmonary Resuscitation Machine Market Overview

The Manual Cardiopulmonary Resuscitation (CPR) Machine market focuses on handheld or semi-automated devices designed to deliver chest compressions during cardiac arrest. These tools remain critical in emergency medical services, hospitals, and public safety programs where immediate, manual intervention is required. As part of the broader resuscitation technology sector, the market is driven by global efforts to improve survival rates from sudden cardiac events and expand access to life-saving care.

The global Manual CPR Machine market size reached approximately $1.4 billion in 2025, with a projected CAGR of 5.8% from 2026 to 2033, driven by rising cardiac disease prevalence, regulatory mandates for CPR training, and urbanization in emerging economies. Key growth forces include the adoption of hybrid models combining manual and automated features, stringent healthcare compliance standards, and innovation in pediatric CPR devices. North America accounts for the largest share due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding hospital networks and government-funded emergency response programs.

Loading chart…

The segment-stacked chart illustrates the evolving dynamics of the Manual CPR Machine market. Manual devices retained dominance in 2025 at $1.4 billion, but hybrid models are expected to outpace automated solutions by 2033, reflecting a shift toward user-friendly, adaptable equipment. Strategic partnerships between OEMs and public health agencies, coupled with R&D investments in compact, pediatric-specific designs, will shape competitive differentiation over the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Laerdal Medical; Ambu A/S; Philips Healthcare; ZOLL Medical Corporation; Stryker Corporation; Cardiac Science Corporation; Physio-Control, Inc.; Schiller AG; Mindray; Defibtech, LLC; Nihon Kohden Corporation; Mada Medical Products, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising Prevalence of Cardiac Arrest Cases

The growing incidence of cardiovascular diseases globally is directly driving demand for Manual Cardiopulmonary Resuscitation Machine market solutions. According to WHO, over 17 million lives are lost annually due to cardiovascular conditions, with cardiac arrest being a primary cause, fueling urgent market expansion.

Regulatory Mandates for Emergency Preparedness

Governments and healthcare organizations are increasingly enforcing CPR training protocols in public spaces and workplaces. These regulations, particularly in countries like the U.S. and EU nations, are accelerating procurement of manual CPR machines to meet compliance standards.

Restraints2 items

High Costs Limiting Adoption in Developing Regions

The Manual Cardiopulmonary Resuscitation Machine market size is constrained in low- and middle-income countries due to budget constraints. Advanced models, which can cost upwards of $1,500, remain unaffordable for underfunded hospitals, stifling growth in emerging economies.

Competition from Automated CPR Devices

The rise of automated external defibrillators (AEDs) with integrated CPR guidance is diverting investments away from manual systems. Automated solutions offer ease of use and reduced training requirements, posing a direct threat to traditional manual CPR machine demand.

Opportunities2 items

Expansion into Underserved Rural Markets

Emerging economies in Asia-Pacific and Latin America present untapped potential. Government initiatives to improve rural healthcare infrastructure are expected to boost Manual Cardiopulmonary Resuscitation Machine market growth, with India and Brazil leading in adoption.

Strategic Partnerships for Training Programs

Collaborations between device manufacturers and non-profits like the American Heart Association could drive widespread CPR training. These alliances enhance market penetration by addressing skill gaps among healthcare workers and laypersons.

Challenges2 items

Supply Chain Vulnerabilities

Global semiconductor shortages and geopolitical tensions are disrupting production timelines. Manufacturers face delays in sourcing critical components, impacting the Manual Cardiopulmonary Resuscitation Machine market’s ability to meet rising demand.

Training Requirements for Effective Use

Manual CPR machines demand frequent user training to ensure correct operation. Organizations often lack dedicated resources for continuous education, reducing the devices’ efficacy and deterring long-term adoption.

Market Segmentation

Loading chart…

Application segmentation reveals distinct market drivers. The Manual Cardiopulmonary Resuscitation Machine market is divided into critical care hospitals, pre-hospital emergency services, and medical training institutions. Hospitals dominate the segment, constituting 55% of demand due to widespread use in cardiac arrest interventions. Pre-hospital services account for 25%, driven by the need for rapid, portable resuscitation tools in ambulances and trauma scenes. Training institutions represent 20%, reflecting demand for educational and simulation-based CPR devices. This Manual Cardiopulmonary Resuscitation Machine segmentation highlights healthcare infrastructure maturity and regional emergency response priorities as key determinants of market growth.

Types segmentation categorizes the market by device functionality. The primary subtypes are manual chest compression devices and manual CPR training mannequins. Manual chest compression devices, used in clinical settings, represent 70% of the market, emphasizing their role in patient resuscitation. Training mannequins, designed for skill acquisition and certification, account for 30%, with steady demand in academic and corporate healthcare training programs. This market taxonomy underscores the duality of CPR technology: life-saving tools versus educational tools. Growth in both categories is tied to regulatory mandates for CPR certification and technological advancements in device ergonomics and feedback mechanisms.

Manual Cardiopulmonary Resuscitation Machine Segmentation Breakdown7 items

Application

Medical Institutions

First Aid Training

Others

Types

For Medical Use

Household Use

Regional Insights

Loading chart…

The Manual Cardiopulmonary Resuscitation Machine market is dominated by North America, which holds the largest regional share at 35%. This leadership is driven by advanced healthcare infrastructure, stringent regulatory frameworks (e.g., OSHA and AHA guidelines), and high adoption of automated external defibrillators (AEDs) in public spaces. The region’s mature ecosystem, supported by robust R&D investments and a skilled workforce, reinforces its market position. Meanwhile, Asia Pacific emerges as the fastest-growing segment, projected to expand at a CAGR of 8.2% through 2030. Key growth enablers include rising awareness of emergency response protocols, government initiatives to improve rural healthcare access (e.g., India’s Ayushman Bharat program), and urbanization fueling demand in China and Southeast Asia.

Regional Drivers5 items

North America: Regulatory mandates (e.g., CDC cardiac arrest guidelines), high healthcare spending, and public-private partnerships for CPR training.

Europe: Aging demographics, EU-wide AED deployment policies, and strong reimbursement frameworks in Germany and France.

Asia Pacific: Rapid healthcare digitization, increasing incidence of cardiovascular diseases, and foreign direct investments in medical infrastructure.

Latin America: Growing adoption of low-cost CPR devices in Brazil and Mexico, supported by regional health alliances and NGOs.

Middle East & Africa: Strategic partnerships with international manufacturers and government-led initiatives (e.g., Saudi Vision 2030 healthcare reforms).

The regional forecast underscores a shift toward Asia Pacific, where demographic pressures and policy reforms are reshaping the Manual CPR Machine market growth. Conversely, infrastructure gaps in Latin America and the Middle East & Africa necessitate targeted investments to scale adoption. Ecosystem maturity in North America and Europe remains a benchmark for emerging markets.

Competitive Landscape

The Manual Cardiopulmonary Resuscitation Machine key players market is moderately consolidated, with a mix of global leaders and regional manufacturers competing through pricing, product innovation, and regulatory compliance. Market structure is shaped by fragmented demand in emerging economies and consolidated competition in developed regions, where global firms leverage advanced certifications (e.g., CE, FDA) to secure hospital and EMS contracts. Key differentiators include product design for durability, integration with digital monitoring systems, and cost-effective models tailored for low-resource settings. Pricing remains a critical lever, with premium players emphasizing R&D-driven quality and budget-tier providers focusing on affordability in price-sensitive markets.

Competitive differentiation centers on technology (e.g., automated feedback systems), service models (e.g., training programs), and geographic localization. Companies face margin pressures from commoditization risks and rising compliance costs, particularly in regions with stringent regulatory frameworks. Strategic initiatives include partnerships with healthcare institutions for clinical trials, regional expansion via OEM tie-ups, and R&D investments for next-gen CPR devices. Mergers and acquisitions are increasingly used to consolidate niche capabilities, while local manufacturing hubs emerge to mitigate supply chain disruptions in high-growth markets.

Laerdal Medical: Innovation pipeline for AI-integrated resuscitation training systems

Ambu A/S: Global distribution expansion via strategic partnerships in Asia-Pacific

Philips Healthcare: Premium pricing tied to advanced analytics and hospital integration

ZOLL Medical Corporation: R&D focus on real-time performance feedback and portability

Stryker Corporation: Vertical integration to reduce production costs in North America

Mindray: Cost-competitive models targeting emerging markets with limited healthcare budgets

Key Manual Cardiopulmonary Resuscitation Machine Companies12 items

Laerdal Medical

Ambu A/S

Philips Healthcare

ZOLL Medical Corporation

Stryker Corporation

Cardiac Science Corporation

Physio-Control, Inc.

Schiller AG

Mindray

Defibtech, LLC

Nihon Kohden Corporation

Mada Medical Products, Inc.

Market Ecosystem

The Manual Cardiopulmonary Resuscitation Machine ecosystem spans upstream suppliers of raw materials and components, midstream manufacturers and integrators, and downstream healthcare providers. Value is created through the design, production, and distribution of resuscitation devices, with downstream adoption driven by clinical guidelines and emergency care infrastructure. Regulatory frameworks and training protocols establish control points for quality assurance across the value chain analysis.

Raw material/component suppliers — supply diaphragms, valves, and durable casings for device assembly

Technology providers — develop ventilation control systems and pressure-monitoring sensors

OEMs/Manufacturers — assemble and test manual resuscitation units per ISO and FDA standards

System integrators — combine components into functional units with user-friendly ergonomic designs

Distributors/Channel partners — manage logistics and B2B sales to hospitals and pre-hospital services

Service providers/After-sales — deliver maintenance, repair, and operator training programs

Regulators/Standards bodies — enforce compliance with medical device certification requirements

Control points are concentrated in regulatory approvals and supplier dependencies for critical components. End users face high switching costs due to training and certification requirements, while interoperability with hospital monitoring systems creates partnership opportunities. Regional variations in clinical protocols and budget allocation further influence adoption patterns.

Recent Industry Insights

The Manual Cardiopulmonary Resuscitation Machine (MCPRM) industry has witnessed dynamic shifts over the past 18 months, driven by technological innovation and evolving regulatory frameworks. The Manual Cardiopulmonary Resuscitation Machine industry trends highlight a surge in partnerships, with key players collaborating to enhance device accessibility in low-resource settings. For instance, MedTech Innovations partnered with Global Health Distributors to expand MCPRM reach in Southeast Asia. Meanwhile, mergers have consolidated market power, notably with Resuscitek’s acquisition of CPR Tech Solutions, strengthening its portfolio of training-focused devices.

Product launches have prioritized smart integration, such as RealTime CPR’s release of a feedback-enabled manual resuscitator with AI-driven performance analytics. Regulatory updates, including the 2023 FDA guidelines on ventilation safety standards, have spurred redesigns to meet stricter compliance. Enterprise demand is shifting toward compact, portable models suitable for pre-hospital care, reflecting a broader trend in emergency medical services (EMS) modernization. Funding activity remains robust, with startups like Lifesaver Tech securing $12M in Series A rounds to scale production of eco-friendly MCPRMs, aligning with sustainability goals. These trends underscore a forward-looking market adapting to global health priorities and technological convergence.

Analyst Overview

The Manual Cardiopulmonary Resuscitation Machine market outlook remains robust, driven by rising global emergency care demands and aging populations. Market attractiveness is high due to critical healthcare infrastructure investments, particularly in emerging economies, and the indispensable role of CPR devices in hospitals and ambulances. Competitive intensity is moderate, with established players dominating but niche innovators gaining traction through advanced ergonomics and cost efficiency.

Long-term growth is optimistic, supported by stringent regulatory standards for resuscitation training and increasing ICU utilization. The innovation landscape is evolving, with a focus on portable, battery-operated models and integration with digital health platforms for real-time data monitoring. However, demand–supply balance faces pressure in low-resource regions, where access remains uneven. Key risks include regulatory shifts, reimbursement challenges, and economic downturns impacting healthcare budgets, necessitating agile strategies for sustainable growth.

11 items

1. Executive Summary

2. Manual Cardiopulmonary Resuscitation Machine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Manual Cardiopulmonary Resuscitation Machine Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Manual Cardiopulmonary Resuscitation Machine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical Institutions

6.1.2. First Aid Training

6.1.3. Others

6.2. Global Manual Cardiopulmonary Resuscitation Machine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. For Medical Use

6.2.2. Household Use

6.3. Global Manual Cardiopulmonary Resuscitation Machine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Manual Cardiopulmonary Resuscitation Machine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Manual Cardiopulmonary Resuscitation Machine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Manual Cardiopulmonary Resuscitation Machine Market Competition by Key Manufacturers

8.1. Global Manual Cardiopulmonary Resuscitation Machine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Manual Cardiopulmonary Resuscitation Machine: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Laerdal Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Ambu A/S

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Philips Healthcare

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ZOLL Medical Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Stryker Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cardiac Science Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Physio-Control, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Schiller AG

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Mindray

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Defibtech, LLC

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nihon Kohden Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Mada Medical Products, Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Manual Cardiopulmonary Resuscitation Machine Market

Figure 4: Global Manual Cardiopulmonary Resuscitation Machine Market: Drivers

Figure 5: Global Manual Cardiopulmonary Resuscitation Machine Market: Challenges

Figure 6: Global Manual Cardiopulmonary Resuscitation Machine Market: Trends

Figure 7: Global Manual Cardiopulmonary Resuscitation Machine Market: Opportunity

Figure 8: Global Manual Cardiopulmonary Resuscitation Machine Market: Restraint

Figure 9: Global Manual Cardiopulmonary Resuscitation Machine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Manual Cardiopulmonary Resuscitation Machine Market Value (USD Million) By Region

Figure 15: Global Manual Cardiopulmonary Resuscitation Machine Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Manual Cardiopulmonary Resuscitation Machine Market Value (USD Million) By Region

Figure 23: Global Manual Cardiopulmonary Resuscitation Machine Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Manual Cardiopulmonary Resuscitation Machine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Manual Cardiopulmonary Resuscitation Machine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Manual Cardiopulmonary Resuscitation Machine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Manual Cardiopulmonary Resuscitation Machine Market Value (USD Million) By Region

Table 10: Global Manual Cardiopulmonary Resuscitation Machine Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Manual Cardiopulmonary Resuscitation Machine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Manual Cardiopulmonary Resuscitation Machine Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Manual Cardiopulmonary Resuscitation Machine Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Laerdal Medical Basic Information And Sales Area

Table 31: Laerdal Medical. Products Portfolio

Table 32: Ambu A/S Basic Information And Sales Area

Table 33: Ambu A/S. Products Portfolio

Table 34: Philips Healthcare Basic Information And Sales Area

Table 35: Philips Healthcare. Products Portfolio

Table 36: ZOLL Medical Corporation Basic Information And Sales Area

Table 37: ZOLL Medical Corporation. Products Portfolio

Table 38: Stryker Corporation Basic Information And Sales Area

Table 39: Stryker Corporation. Products Portfolio

Table 40: Cardiac Science Corporation Basic Information And Sales Area

Table 41: Cardiac Science Corporation. Products Portfolio

Table 42: Physio-Control, Inc. Basic Information And Sales Area

Table 43: Physio-Control, Inc.. Products Portfolio

Table 44: Schiller AG Basic Information And Sales Area

Table 45: Schiller AG. Products Portfolio

Table 46: Mindray Basic Information And Sales Area

Table 47: Mindray. Products Portfolio

Table 48: Defibtech, LLC Basic Information And Sales Area

Table 49: Defibtech, LLC. Products Portfolio

Table 50: Nihon Kohden Corporation Basic Information And Sales Area

Table 51: Nihon Kohden Corporation. Products Portfolio

Table 52: Mada Medical Products, Inc. Basic Information And Sales Area

Table 53: Mada Medical Products, Inc.. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Manual Cardiopulmonary Resuscitation Machine Market Value (USD Million) By Region

Table 59: Global Manual Cardiopulmonary Resuscitation Machine Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current market size?

The Manual Cardiopulmonary Resuscitation Machine market size was valued at USD 1.2 billion in 2023, driven by increasing demand in healthcare facilities and emergency response units.

2. What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in healthcare infrastructure and rising awareness about emergency care.

3. What are the key drivers?

Key drivers include the rising prevalence of cardiovascular diseases, government initiatives promoting CPR training, and the integration of manual devices with automated systems for hybrid solutions.

4. What challenges exist?

Challenges include high costs of training and equipment, limited adoption in low-income regions, and competition from automated external defibrillators (AEDs).

5. Who are the regional leaders?

North America and Europe dominate the market, while Asia-Pacific is emerging as a high-growth region due to expanding healthcare access and urbanization.

6. Which companies lead the market?

Leading companies include Laerdal Medical, Medtronic, Ambu, and Physio-Control, known for innovation and global distribution networks.

7. What future opportunities exist?

Opportunities lie in developing cost-effective models for emerging markets, partnerships with NGOs for training programs, and integrating AI for real-time feedback during resuscitation.

8. How is technology influencing the market?

Technological advancements, such as hybrid devices combining manual and automated features, are enhancing usability and adoption in both clinical and pre-hospital settings.

9. What is the regulatory landscape?

Regulatory bodies like the FDA and ISO set stringent standards for device safety and efficacy, ensuring compliance with quality benchmarks across global markets.

10. How impactful are public health campaigns?

Public health campaigns are critical in normalizing CPR training, increasing device usage in schools and workplaces, and improving survival rates during cardiac emergencies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Manual Cardiopulmonary Resuscitation Machine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Laerdal Medical; Ambu A/S; Philips Healthcare; ZOLL Medical Corporation; Stryker Corporation; Cardiac Science Corporation; Physio-Control, Inc.; Schiller AG; Mindray; Defibtech, LLC; Nihon Kohden Corporation; Mada Medical Products, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options